# Agilent Technologies Inc (NYSE: A), Boulder, CO – FDA Inspections

Source: https://www.keypedia.com/companies/agilent-technologies-inc/865fe026-9db0-4e3e-bc4a-e0d25b465093

> Inspection records and compliance data for Agilent Technologies Inc in Boulder, Colorado. 3 FDA inspections on record, 1 Form 483, last inspected May 06, 2026. Publicly traded as NYSE: A.

---

## Details

- Name: Agilent Technologies Inc
- FEI Number: 3007057070
- Business Operations: API MANUFACTURE
- Address Line 1: 5555 Airport Blvd
- City: Boulder
- State: Colorado
- Zip Code: 80301
- Country Name: United States
- Address: 5555 Airport Blvd, Boulder, Colorado 80301, United States
- Country: United States

## Stock

- Stock ticker: A
- Exchange: NYSE
- Share price: $173.04
- Market cap: $48.8B
- Price as of: November 13, 2026

## Related Documents

- FDA Inspection 1319444 - Agilent Technologies Inc - 2026-05-06 — source: FDA, date: May 6, 2026
- [EIR - Agilent Technologies Inc - 2019-08-02](https://www.keypedia.com/records/eir/agilent-technologies-inc/d1aa85e6-6bdc-43d3-8490-e6a8f66dbf35) — source: FDA, date: August 2, 2019
- [483 - Agilent Technologies Inc - 2019-08-02](https://www.keypedia.com/records/483/agilent-technologies-inc/3b469df1-6b6c-451e-b98c-b3325cf97623) — source: FDA, date: August 2, 2019
- [FDA Inspection 1098600 - Agilent Technologies Inc - 2019-08-02](https://www.keypedia.com/records/fda_inspections/agilent-technologies-inc/849ce9ea-e734-4773-b539-9fcc7874aa65) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 2, 2019
- FDA Inspection 1045456 - Agilent Technologies Inc - 2018-02-21 — source: FDA, date: February 21, 2018

## Related Companies

- [Biocon Limited](https://www.keypedia.com/companies/biocon-limited/7b8920c7-f5be-4f17-8100-3bede3943790)
- [Organo Sintesis, S.A. De C.V.](https://www.keypedia.com/companies/organo-sintesis-sa-de-cv/0d8f4d8d-0fbd-4c4a-8362-439c74e4f37d)
- [MSN Laboratories Private Limited, Unit-II](https://www.keypedia.com/companies/msn-laboratories-private-limited-unit-ii/539d7af5-94e6-4abe-b01b-fa911be84d2a)
- [Biocon Biosphere Limited](https://www.keypedia.com/companies/biocon-biosphere-limited/4c5f824e-c399-4c0e-91be-45739741dc2c)
- [ImClone Systems, LLC](https://www.keypedia.com/companies/imclone-systems-llc/ccde4edf-e0cb-4367-a935-725ce0bad4d3)
- [SpecGx LLC](https://www.keypedia.com/companies/specgx-llc/715bb75a-8d3a-4469-9e6d-f617c2f39c93)
- [GlaxoSmithKline dba Human Genome Sciences Inc](https://www.keypedia.com/companies/glaxosmithkline-dba-human-genome-sciences-inc/c3dd2e54-125d-4d56-b0dc-18cb333074cc)
- [Ercros S.A.](https://www.keypedia.com/companies/ercros-sa/adeb63ee-2821-47de-939a-39c363e39854)
- [Cipla Ltd.](https://www.keypedia.com/companies/cipla-ltd/d90a952b-3052-4e33-9969-5db3f2bbae82)
- [QOL Medical LLC](https://www.keypedia.com/companies/qol-medical-llc/83e2d372-ec27-4388-ab26-9774d5edcc55)

## Related Officers

- [company_representative](https://www.keypedia.com/people/brian-s-carothers/b24c69ae-0bfd-460c-82c6-658210813c26)
- [Compliance Officer / Investigator](https://www.keypedia.com/people/erika-v-butler/3e654530-4c29-403d-880e-a5422315c3c0)
